Glofitamab as a Bridge to and/or Consolidation Post Autologous Stem Cell Transplant in Patients With Relapsed B Cell Lymphomas
Clinical trial NCT07387848 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07387848
- Sponsor
- American University of Beirut Medical Center
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-04-15
- Primary completion
- 2031-12-15
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.